TelAbortion Study

Why is this study being done?

In a standard medical abortion, a woman must visit the abortion provider in person at least once. However, women may find it challenging to reach an abortion provider due to distance, the costs of travel, the need for childcare, lost wages, or for other reasons. In this study, women will be evaluated by videoconference, and if they are eligible, the medical abortion pills will be sent in the mail. Women will obtain an ultrasound and other tests at facilities near their homes before and after the procedure. The
study will use the same FDA-approved medicines that are used for all medical abortions at OHSU.

Purpose of this study:

  • To assess service provision of medical abortion through telemedicine
  • To improve access to abortion for women who may find it challenging or inconvenient to come for an in-person visit with an abortion provider

Eligibility

You may qualify for this study if you:

  1. Are pregnant and want a medical abortion
  2. Live in Oregon or Washington State
  3. Are not more than 70 days pregnant (10 weeks) at the time of study enrollment
  4. Have access to a computer with a webcam and microphone
  5. Can speak and understand English

Cost of Participation

Qualified participants will pay any out-of-pocket costs for care received at OHSU. You or your insurance carrier may be responsible for services obtained at OHSU and elsewhere.

Who Do I Contact for Additional Information?

To find out more information and to learn if you are qualified to participate, please call the Women’s Health Research Unit’s confidential TelAbortion Study line at 503-494-3959, or email us at whru@ohsu.edu.

Additional information is available at the study website.